Insights

Gathering insights about InMed…

Similar companies to InMed

InMed Tech Stack

Media & News

InMed Reports Second Quarter Fiscal 2026 Financial Results and Provides Business Update
Vancouver, British Columbia--(Newsfile Corp. - February 11, 2026) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical drug development company focused on developing a pipeline of proprietary small-molecule drug candidates for diseases with high unmet medical needs, today reports financial results for its second quarter of fiscal year 2026, which ended December 31, 2025. The Company's full financial statements and related MD&A for the second quarter ended December 31, 2025 are available at www.inmedpharma.com, www.sedarplus.ca and at www.sec.gov.
Feb 11, 2026 | www.newsfilecorp.com
InMed Pharmaceuticals Inc. (INM) Shareholder/Analyst Call Prepared Remarks Transcript
InMed Pharmaceuticals Inc. (INM) Shareholder/Analyst Call Prepared Remarks Transcript
Dec 17, 2025 | seekingalpha.com
InMed Announces Results of 2025 Annual General and Special Meeting
Vancouver, British Columbia--(Newsfile Corp. - December 17, 2025) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, today confirmed that, at its annual general and special meeting of shareholders held on December 17, 2025 (the "Meeting"), the matters put forward before shareholders for consideration and approval as set out in InMed's notice of meeting and management information circular, dated November 3, 2025, were voted upon by the shareholders. A total of 993,491 common shares of the Company, representing approximately 35.43% of the Company's 2,804,186 issued and outstanding common shares, were represented in person or by proxy at the Meeting.
Dec 17, 2025 | www.newsfilecorp.com
InMed Provides Update on BayMedica Commercial Business
Vancouver, British Columbia--(Newsfile Corp. - December 12, 2025) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, today released the following statement. Recently, H.R.
Dec 12, 2025 | www.newsfilecorp.com
InMed Announces Successful Completion of Pharmacokinetic Studies in Large Animal Model for Its Alzheimer's Disease Candidate INM-901
Data demonstrate a favorable bioavailability profile of INM-901 oral formulation Data will support design and planning of first in human clinical trials Preparing for pre-IND meeting with the FDA Vancouver, British Columbia--(Newsfile Corp. - November 18, 2025) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company developing a pipeline of proprietary small-molecule drug candidates for diseases with high unmet medical needs, today announced the successful completion of pharmacokinetic ("PK") studies in large animal models for its Alzheimer's disease candidate INM-901. This marks the first preclinical study in which the oral formulation of INM-901 was administered in large animals.
Nov 18, 2025 | www.newsfilecorp.com
InMed Reports First Quarter Fiscal 2026 Financial Results and Provides Business Update
Vancouver, British Columbia--(Newsfile Corp. - November 6, 2025) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical drug development company focused on developing a pipeline of proprietary small-molecule drug candidates for diseases with high unmet medical needs, today reports financial results for its first quarter of fiscal year 2026, which ended September 30, 2025. The Company's full financial statements and related MD&A for the first quarter ended September 30, 2025, are available at www.inmedpharma.com, www.sedar.com and at www.sec.gov.
Nov 06, 2025 | www.newsfilecorp.com
Inmed Pharmaceuticals Appoints Mr. John Bathery to Its Board of Directors
Vancouver, British Columbia--(Newsfile Corp. - October 16, 2025) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, today announced the appointment of Mr. John Bathery to its Board of Directors, effective immediately.
Oct 16, 2025 | www.newsfilecorp.com

InMed's Email Address Formats

InMed uses at least 1 format(s):

InMed Email Formats	Example	Percentage
FLast@inmeddiagnostics.com	JDoe@inmeddiagnostics.com	72%
First.Last@inmeddiagnostics.com	John.Doe@inmeddiagnostics.com	17%
First@inmeddiagnostics.com	John@inmeddiagnostics.com	8%
F.Last@inmeddiagnostics.com	J.Doe@inmeddiagnostics.com	3%

Frequently Asked Questions

Where is InMed's headquarters located?

InMed's main headquarters is located at United States. The company has employees across 5 continents, including North AmericaSouth AmericaEurope.

What is InMed's phone number?

You can contact InMed's main corporate office by phone at

+1-803-988-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is InMed's stock symbol?

InMed is a publicly traded company; the company's stock symbol is INM.

What is InMed's official website and social media links?

InMed's official website is inmeddiagnostics.com and has social profiles on LinkedIn.

How much revenue does InMed generate?

As of January 2026, InMed's annual revenue is estimated to be $5M.

What is InMed's NAICS code?

InMed's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does InMed have currently?

As of January 2026, InMed has approximately 155 employees across 5 continents, including North AmericaSouth AmericaEurope. Key team members include Owner: R. L.Owner: S. F.Executive Vice President: T. J.. Explore InMed's employee directory with LeadIQ.

What industry does InMed belong to?

InMed operates in the Medical Equipment Manufacturing industry.

What is InMed's email format?

InMed's email format typically follows the pattern of FLast@inmeddiagnostics.com. Find more InMed email formats with LeadIQ.

InMed

Q: What is InMed's official website and social media links?

InMed's official website is inmeddiagnostics.com. InMed has social profiles on LinkedIn.

Q: How many employees does InMed have currently?

InMed has approximately 155 employees.

Medical Equipment ManufacturingUnited States51-200 Employees

Imaging centers including over 15 centers thru out the United states, specializing in MRI, CT, X-Ray, Breast MR, ultrasound.

Company Overview

Headquarters: United States
Phone number: +1-803-988-****
Website: inmeddiagnostics.com
Stock Symbol: INM
NAICS Code: 3391 - Medical Equipment and Supplies Manufacturing
Employees: 51-200

Media & News

Funding & Financials

$50M$100M
InMed's revenue is estimated to be in the range of $50M$100M

Funding & Financials

$50M$100M
InMed's revenue is estimated to be in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to InMed

AGFA HealthCare

GE HealthCare

Siemens Healthineers

InMed Tech Stack

Media & News

InMed Reports Second Quarter Fiscal 2026 Financial Results and Provides Business Update

InMed Pharmaceuticals Inc. (INM) Shareholder/Analyst Call Prepared Remarks Transcript

InMed Announces Results of 2025 Annual General and Special Meeting

InMed Provides Update on BayMedica Commercial Business

InMed Announces Successful Completion of Pharmacokinetic Studies in Large Animal Model for Its Alzheimer's Disease Candidate INM-901

InMed Reports First Quarter Fiscal 2026 Financial Results and Provides Business Update

Inmed Pharmaceuticals Appoints Mr. John Bathery to Its Board of Directors

InMed's Email Address Formats

Frequently Asked Questions

Where is InMed's headquarters located?

What is InMed's phone number?

What is InMed's stock symbol?

What is InMed's official website and social media links?

How much revenue does InMed generate?

What is InMed's NAICS code?

How many employees does InMed have currently?

What industry does InMed belong to?

What is InMed's email format?

InMed

Company Overview

Media & News

InMed Reports Second Quarter Fiscal 2026 Financial Results and Provides Business Update

InMed Pharmaceuticals Inc. (INM) Shareholder/Analyst Call Prepared Remarks Transcript

InMed Announces Results of 2025 Annual General and Special Meeting

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?